Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00368784 · ClinicalTrials.gov registry record
T Cell Repertoire Analysis of Immune Mediated Skin Diseases
A clinical trial, sponsored by University of California, Davis.
- Completed
- Registry status
- 426
- Enrollment target
NCT00368784: Completed study, sponsored by University of California, Davis.
NCT00368784 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 426 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00368784 has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 426 participants
- Enrollment target
Study Summary
This study is designed to identify the cells of the immune system that cause skin disease such as psoriasis and mycosis fungoides. Blood samples from many patients will be compared in hopes of finding common cells and molecules responsible for skin diseases. Results of this study will increase our knowledge about immune mediated skin disease.
Primary Outcome
These samples will then be used for PCR analysis and T cell cloning.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 426 participants |
| Start Date | 2007-01 |
| Est. Completion | 2020-11 |
What the finished NCT00368784 record still lists
NCT00368784 is an observational study that tracks outcomes without assigning an intervention. The registered 426 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00368784 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00368784 about?
NCT00368784 is a clinical study titled "T Cell Repertoire Analysis of Immune Mediated Skin Diseases". This study is designed to identify the cells of the immune system that cause skin disease such as psoriasis and mycosis fungoides. Blood samples from many patients will be compared in hopes of finding common cells and molecules responsible for skin diseases. Results of this study will increase our k...
What is the current status of trial NCT00368784?
This trial is currently completed. The enrollment target is 426 participants. The study started on 2007-01. Estimated completion is 2020-11.
Who is sponsoring clinical trial NCT00368784?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06790784 · 426 participants · Phase 3
Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR
- NCT04265430 · 425 participants · Phase 4
Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors
- NCT04278690 · 425 participants · NA
Supporting Safe Use of Medications by Parents After Infant Discharge From the Neonatal Intensive Care Unit
- NCT05321368 · 425 participants · NA
A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia